Marketing-authorisation holder · Spain
Accord Healthcare S.L.U.
823 medicines in 3 countries, as authorisation holder and marketer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Spain
823 medicines in 3 countries, as authorisation holder and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 823
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABIRATERONA ACCORD 250 MG COMPRIMIDOS EFG250 mg · Comprimido | Abiraterone | Spain | Authorised | 2022 |
| ABIRATERONA ACCORD 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG500 mg · Comprimido recubierto con película | Abiraterone | Spain | Marketed | 2022 |
| Abiraterone Accord | Abiraterone | EU (EMA) | Authorised | 2021 |
| ABIRATERONE ACCORDCompressa rivestita con film | Abiraterone | Italy | Authorised | |
| ACCOFILSoluzione iniettabile o per infusione | Filgrastim | Italy | Authorised | |
| Accofil | Filgrastim | EU (EMA) | Authorised | 2014 |
| ACCOFIL 12 MU/0,2 ML SOLUCION INYECTABLE Y PARA PERFUSION EN JERINGA PRECARGADA0,12 mg · Solución inyectable y para perfusión en jeringa precargada | Filgrastim | Spain | Marketed | 2021 |
| Accofil 30 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada0,3 mg · Solución inyectable y para perfusión en jeringa precargada | Filgrastim | Spain | Authorised | 2014 |
| Accofil 30 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada0,3 mg · Solución inyectable y para perfusión en jeringa precargada | Filgrastim | Spain | Marketed | 2015 |
| Accofil 30 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada0,3 mg · Solución inyectable y para perfusión en jeringa precargada | Filgrastim | Spain | Authorised | 2014 |
| Accofil 30 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada0,3 mg · Solución inyectable y para perfusión en jeringa precargada | Filgrastim | Spain | Marketed | 2015 |
| ACCOFIL 48 MU/0,5 ml SOLUCION INYECTABLE Y PARA PERFUSION EN JERINGA PRECARGADA0,48 mg · Solución inyectable y para perfusión en jeringa precargada | Filgrastim | Spain | Authorised | 2020 |
| Accofil 48 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada0,48 mg · Solución inyectable y para perfusión en jeringa precargada | Filgrastim | Spain | Authorised | 2014 |
| Accofil 48 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada0,48 mg · Solución inyectable y para perfusión en jeringa precargada | Filgrastim | Spain | Marketed | 2015 |
| Accofil 48 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada0,48 mg · Solución inyectable y para perfusión en jeringa precargada | Filgrastim | Spain | Marketed | 2015 |
| Accofil 48 MU/0,5 ml solucion inyectable y para perfusion en jeringa precargada0,48 mg · Solución inyectable y para perfusión en jeringa precargada | Filgrastim | Spain | Authorised | 2014 |
| ACCOFIL 70 MU/0,73 ML SOLUCION INYECTABLE Y PARA PERFUSION EN JERINGA PRECARGADA0,96 mg/ml · Solución inyectable y para perfusión en jeringa precargada | Filgrastim | Spain | Marketed | 2021 |
| ACECLOFENAC ACCORDCompressa rivestita con film | Aceclofenac | Italy | Authorised | |
| ACICLOVIR ACCORD 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION25 mg · Concentrado para solución para perfusión | Aciclovir | Spain | Marketed | 2020 |
| ACICLOVIR ACCORD 250 MG POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN EFG250 mg · Liofilizado para solución para perfusión | Aciclovir | Spain | Marketed | 1998 |
| ACIDO IBANDRONICO ACCORDConcentrato per soluzione per infusione | Ibandronic acid | Italy | Authorised | |
| Acido Ibandronico Accord 2 mg concentrado para solucion para perfusion EFG2,000 mg · Concentrado para solución para perfusión | Ibandronic acid | Spain | Authorised | 2013 |
| Acido Ibandronico Accord 6 mg concentrado para solucion para perfusion EFG6,000 mg · Concentrado para solución para perfusión | Ibandronic acid | Spain | Authorised | 2013 |
| ACIDO MICOFENOLICO ACCORDCompressa gastroresistente | Mycophenolate mofetil | Italy | Authorised | |
| ACIDO ZOLEDRONICO ACCORDConcentrato per soluzione per infusione | Zoledronic acid | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 546 | 364 | 182 | CompaniesAll medicines |
| Italy | 195 | 195 | 0 | CompaniesAll medicines |
| European Union (EMA) | 82 | 70 | 12 | CompaniesAll medicines |
Also in the registers of Netherlands, Romania
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.